opc 12759 has been researched along with Mouth Ulcer in 2 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakashima, T | 1 |
Sako, N | 1 |
Matsuda, T | 1 |
Uematsu, N | 1 |
Sakurai, K | 1 |
Ishida, T | 1 |
Taylor, J | 1 |
Glenny, AM | 1 |
Walsh, T | 1 |
Brocklehurst, P | 1 |
Riley, P | 1 |
Gorodkin, R | 1 |
Pemberton, MN | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease: A Randomized Clinical Trial[NCT06084624] | Phase 1/Phase 2 | 40 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for opc 12759 and Mouth Ulcer
Article | Year |
---|---|
Interventions for the management of oral ulcers in Behçet's disease.
Topics: Acyclovir; Adrenal Cortex Hormones; Alanine; Behcet Syndrome; Colchicine; Cyclosporine; Etanercept; | 2014 |
1 other study available for opc 12759 and Mouth Ulcer
Article | Year |
---|---|
Novel submicronized rebamipide liquid with moderate viscosity: significant effects on oral mucositis in animal models.
Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Cautery; Disease Models, Animal; Drug Car | 2014 |